Helen Louise Collins insider trades

Open-market stock purchases and sales by Helen Louise Collins, CHIEF MEDICAL OFFICER at Enliven Therapeutics, Inc, from SEC Form 4 filings since Mar 20, 2017.

Recent trades

DateStockTradeValue
Sep 17, 2026ELVN Enliven Therapeutics, IncSold$146K
Sep 17, 2026ELVN Enliven Therapeutics, IncSold$93.5K
Sep 17, 2026ELVN Enliven Therapeutics, IncSold$12.4K
Sep 17, 2026ELVN Enliven Therapeutics, IncBought (not open market)—
Aug 17, 2026ELVN Enliven Therapeutics, IncSold$228K
Aug 17, 2026ELVN Enliven Therapeutics, IncSold$65.3K
Aug 17, 2026ELVN Enliven Therapeutics, IncBought (not open market)—
Jul 17, 2026ELVN Enliven Therapeutics, IncSold$11.6K
Jul 17, 2026ELVN Enliven Therapeutics, IncSold$23.7K
Jul 17, 2026ELVN Enliven Therapeutics, IncBought (not open market)—
Jul 17, 2026ELVN Enliven Therapeutics, IncSold$3.4K
Jul 17, 2026ELVN Enliven Therapeutics, IncSold$108K
Jul 17, 2026ELVN Enliven Therapeutics, IncSold$117K
Jun 17, 2026ELVN Enliven Therapeutics, IncSold$54.3K
Jun 17, 2026ELVN Enliven Therapeutics, IncSold$114K
Jun 17, 2026ELVN Enliven Therapeutics, IncSold$50.7K
Jun 17, 2026ELVN Enliven Therapeutics, IncBought (not open market)—
Jun 4, 2026KURA Kura Oncology, IncBought (not open market)—
May 18, 2026ELVN Enliven Therapeutics, IncSold$137K
May 18, 2026ELVN Enliven Therapeutics, IncSold$52.4K
May 18, 2026ELVN Enliven Therapeutics, IncSold$9.2K
May 18, 2026ELVN Enliven Therapeutics, IncBought (not open market)—
Apr 17, 2026ELVN Enliven Therapeutics, IncSold$6.4K
Apr 17, 2026ELVN Enliven Therapeutics, IncSold$115K
Apr 17, 2026ELVN Enliven Therapeutics, IncSold$117K

Companies traded

  • ELVN Enliven Therapeutics, Inc: 26 sales, last Sep 17, 2026
  • KURA Kura Oncology, Inc: other filings, last Jun 4, 2026
  • IOBT IO Biotech, Inc: other filings, last Jun 5, 2025
  • FPRX Five Prime Therapeutics, Inc: other filings, last Apr 16, 2021

Get free alerts when Helen Louise Collins files a new trade →